These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Metformin Results in Diametrically Opposed Effects by Targeting Non-Stem Cancer Cells but Protecting Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma. Kuo SZ; Honda CO; Li WT; Honda TK; Kim E; Altuna X; Abhold E; Wang-Rodriguez J; Ongkeko WM Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621095 [TBL] [Abstract][Full Text] [Related]
23. mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC. Coppock JD; Vermeer PD; Vermeer DW; Lee KM; Miskimins WK; Spanos WC; Lee JH Oncotarget; 2016 Apr; 7(17):24228-41. PubMed ID: 27015118 [TBL] [Abstract][Full Text] [Related]
24. HPV detection and genotyping of head and neck cancer biopsies by molecular testing with regard to the new oropharyngeal squamous cell carcinoma classification based on HPV status. Veyer D; Wack M; Grard O; Bonfils P; Hans S; Bélec L; Badoual C; Péré H Pathology; 2019 Jun; 51(4):421-425. PubMed ID: 31005250 [TBL] [Abstract][Full Text] [Related]
25. Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity. Nickson CM; Moori P; Carter RJ; Rubbi CP; Parsons JL Oncotarget; 2017 May; 8(18):29963-29975. PubMed ID: 28415784 [TBL] [Abstract][Full Text] [Related]
26. Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells. Wu X; Yeerna H; Goto Y; Ando T; Wu VH; Zhang X; Wang Z; Amornphimoltham P; Murphy AN; Tamayo P; Chen Q; Lippman SM; Gutkind JS Cancer Res; 2019 Sep; 79(17):4360-4370. PubMed ID: 31292160 [TBL] [Abstract][Full Text] [Related]
27. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy. Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574 [TBL] [Abstract][Full Text] [Related]
28. Subjugation of TGFβ Signaling by Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma Shifts DNA Repair from Homologous Recombination to Alternative End Joining. Liu Q; Ma L; Jones T; Palomero L; Pujana MA; Martinez-Ruiz H; Ha PK; Murnane J; Cuartas I; Seoane J; Baumann M; Linge A; Barcellos-Hoff MH Clin Cancer Res; 2018 Dec; 24(23):6001-6014. PubMed ID: 30087144 [TBL] [Abstract][Full Text] [Related]
29. Sensitivity of human papillomavirus‑positive and ‑negative oropharyngeal cancer cell lines to ionizing irradiation. Holzhauser S; Pirotte E; Jones J; Owens D; Al-Hussaini A; Giles P; Evans M; Man S; Powell N Oncol Rep; 2020 Oct; 44(4):1717-1726. PubMed ID: 32945506 [TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma. Dalianis T Presse Med; 2014 Dec; 43(12 Pt 2):e429-34. PubMed ID: 25455638 [TBL] [Abstract][Full Text] [Related]
31. HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence. Speel EJ Recent Results Cancer Res; 2017; 206():57-72. PubMed ID: 27699529 [TBL] [Abstract][Full Text] [Related]
32. In vitro effects of gamma-secretase inhibition in HPV-positive and HPV-negative head and neck squamous cell carcinoma. Varatanovic S; Maier T; Al-Gboore S; Stoiber S; Kandathil SA; Quint C; Brennus C; Heiduschka G; Kadletz-Wanke L; Brkic FF Invest New Drugs; 2023 Apr; 41(2):193-201. PubMed ID: 36809443 [TBL] [Abstract][Full Text] [Related]
33. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Divya CS; Pillai MR Mol Carcinog; 2006 May; 45(5):320-32. PubMed ID: 16526022 [TBL] [Abstract][Full Text] [Related]
34. Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant. Liu C; Guo T; Xu G; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Khan Z; Fisch KM; Califano J Clin Cancer Res; 2018 Oct; 24(20):5123-5132. PubMed ID: 29945995 [No Abstract] [Full Text] [Related]
35. Human Papillomavirus and Oropharyngeal Cancer. Tanaka TI; Alawi F Dent Clin North Am; 2018 Jan; 62(1):111-120. PubMed ID: 29126488 [TBL] [Abstract][Full Text] [Related]
36. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma. Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222 [TBL] [Abstract][Full Text] [Related]
37. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study. Jouhi L; Datta N; Renkonen S; Atula T; Mäkitie A; Haglund C; Ahmed A; Syrjänen S; Grénman R; Auvinen E; Lehtonen S; Hagström J Tumour Biol; 2015 Sep; 36(10):7755-64. PubMed ID: 25941114 [TBL] [Abstract][Full Text] [Related]
38. Heterogeneous nuclear ribonucleoprotein K is overexpressed and contributes to radioresistance irrespective of HPV status in head and neck squamous cell carcinoma. Kähler J; Hafner S; Popp T; Hermann C; Rump A; Port M; Steinestel K; Eder S Int J Mol Med; 2020 Nov; 46(5):1733-1742. PubMed ID: 32901844 [TBL] [Abstract][Full Text] [Related]
39. Detection of human papillomavirus in cases of head and neck squamous cell carcinoma by RNA-seq and VirTect. Khan A; Liu Q; Chen X; Stucky A; Sedghizadeh PP; Adelpour D; Zhang X; Wang K; Zhong JF Mol Oncol; 2019 Apr; 13(4):829-839. PubMed ID: 30597724 [TBL] [Abstract][Full Text] [Related]
40. Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63α. Citro S; Bellini A; Miccolo C; Ghiani L; Carey TE; Chiocca S Br J Cancer; 2019 Mar; 120(6):658-667. PubMed ID: 30765872 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]